Charged Alpha Stock Encyclopedia

Charged Alpha Stock Encyclopedia

By Colton ThomasBusinessInvesting
Download on the App Store

Charged Alpha Stock Encyclopedia episodes

  • Marathon Petroleum (MPC): A 24% Beat, A $5.1B Quarter - And 45% Of It Is A Different Stock
    Marathon Petroleum Corporation (MPC) Q2 2026 — Net income attributable to MPC $5,138M, or $17.73 diluted, vs $14.27 consensus - a 24% beat, and GAAP equals adjusted with ZERO add-backs. Revenue $52,337M, +53.5%. Adjusted EBITDA $8,460M vs $3,286M. Refining margin $36.33/bbl vs $17.58. But throughput FELL 3.8% to 2,944 mbpd and utilisation dropped to 94% from 97%. MPC closed $312.61, up just 1.8%.
    Marathon Petroleum just printed the biggest quarter in its history - $5.1 billion of profit, $17.73 a share against $14.27 expected, revenue up 53% - and the stock closed up 1.8%. Underneath: every dollar of it came from one line, the refining margin, which more than doubled to $36.33 a barrel while the volume through those same refineries FELL 3.8%. And 45% of Marathon's market value is a separately listed stock.
    THE CALL: HOLD (3/5, A HISTORIC QUARTER, AT A PRICE THAT ALREADY ASSUMES A NORMAL ONE) — base-case value ~$327.0 vs ~$312.61 today.
    KEY METRICS:
    - CALL: HOLD 3/5, fair value ~$327 vs the $312.61 close (+4.6%). This is a sum-of-the-parts, not a DCF, because 45% of MPC is a listed stock. Refining stub at mid-cycle: $20.50/bbl margin less $5.85 operating and $6.00 distribution = $8.75/bbl segment profit on 1,077M barrels = $9.42B; plus renewables $0.35B, less corporate $1.05B = $8.72B, at 6.25x = $54.5B. Plus MPC's 647M MPLX units at 11.0x = $37.6B. Less parent net debt $0.41B. Equity $91.7B on 280,824,763 shares = $327. Bear $232-$265, bull $375-$435. The Street: Buy, ~$330.
    - WHICH EPS IS REAL - AND FOR ONCE THEY ARE THE SAME. Marathon's own reconciliation: net income attributable to MPC $5,138M, pre-tax adjustments ZERO, adjusted net income $5,138M. Diluted $17.73. Adjusted diluted $17.73. Identical. They do adjust when there is something to adjust - a $32M clean-fuel tax credit taken out over six months, which is why H1 reads $19.30 GAAP vs $19.22 adjusted. In the June quarter, nothing. So the 24% beat is apples-to-apples on both bases.
    - THE BEAT WAS 105% MARGIN AND MINUS 4% VOLUME. Net throughput 2,944 mbpd over 91 days = 267.9M barrels. Refining margin went $17.58 to $36.33, worth +$5,023M on this quarter's barrels. The volume decline, at last year's margin, is worth -$186M. Segment profit actually rose $4,765M. Crude refined fell 2,883 to 2,798 mbpd; utilisation 97% to 94%; Mid-Continent ran 11.5% below last year. Marathon processed LESS oil and earned four times the money. Gulf Coast $36.52 vs $15.17, Mid-Con $33.68 vs $17.86, West Coast $41.28 vs $23.18.
    - THE BALANCE SHEET SCREENS WRONG. Every screen shows $32,816M of debt and ~1.5x net debt/EBITDA. But $25,640M of that is MPLX's, and the 10-Q states plainly that MPLX's creditors have NO recourse to MPC's general credit. At the parent: $7,176M of debt against ~$6,768M of MPC-level cash ($7,768M consolidated less $1,000M at MPLX) = roughly $408M of net debt. Effectively unlevered. One caution: of $11,448M of H1 operating cash flow, about $3,190M was working capital - 28% is timing, not earnings.
    - 45% OF THE MARKET CAP IS A LISTED STOCK. MPC owns 647 million MPLX common units - 64% of the partnership - worth $39.2B at MPLX's $60.51 close. On 280.8M MPC shares that is $139.40 of the $312.61 price. You pay ~$173 a share for thirteen refineries. And the halves behave differently: refining segment profit +252%, midstream +8% ($1,778M vs $1,641M), fee-based and indifferent to the crack. Cost: $400M of the quarter's net income belongs to MPLX's public holders. Buyback: 9M shares at $258.36 in Q2, 13M YTD, $6.1B left.
    What to watch: Changes our mind UP: two more quarters of refining segment profit above $25/bbl with utilisation back over 96%, or MPLX reaffirming 12.5% distribution growth into 2028. Confirms the bear: refining margin back under $15/bbl, or the buyback slowing below $1.5B a quarter - management telling you they no longer see value either. We'd buy at $245-$260, where Marathon itself repurchased 9M shares at $258.36.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    14 min
  • Toast (TOST): The 34 Cents Everyone Printed Wasn’t GAAP - And Cash Flow Fell 37%
    Toast, Inc. (TOST) Q2 2026 — Revenue $1,908M, +23.1%, vs ~$1,873M consensus. GAAP diluted EPS $0.26 vs $0.13 (FactSet est $0.20) - the $0.34 in the data feeds is an adjusted figure Toast never published. Net income $154M. Adjusted EBITDA $221M. ARR $2,409M +25%. ~180,000 locations, record 9,500 net adds. GPV $60.7B. Free cash flow $130M vs $208M. FY26 guidance RAISED. TOST closed $33.81.
    Toast beat on revenue, beat on GAAP EPS, added a record 9,500 net locations and RAISED full-year guidance - and the stock did nothing. Underneath: the 34 cents half the wires printed is not what Toast filed (the release says $0.26), and free cash flow fell 37% in the quarter net income nearly doubled.
    THE CALL: HOLD (3/5, AN EXCELLENT BUSINESS, ALREADY PRICED LIKE ONE) — base-case value ~$32.0 vs ~$33.81 today.
    KEY METRICS:
    - CALL: HOLD 3/5, fair value ~$32 vs the $33.81 close (-5%). A 10-year DCF on OWNER free cash flow: start from Toast's own FY26 adjusted EBITDA guidance ($805-825M), charge stock compensation as a cost, then take out capex and the cash tax that arrives as the $982M loss shield burns off. 2027 owner FCF $646M, rising to $1,276M by 2031. At 10/11/12%: bear $21/$18/$17, base $38/$33/$29, bull $55/$46/$40; weighted 25/50/25 = ~$32. Our base-case enterprise value is $17.70B. The market is at $17.9B. One percent apart. The Street: Buy, $35.71.
    - WHICH EPS IS REAL. The release says, in plain English, 'Diluted earnings per share was $0.26 in Q2 2026' vs $0.13. Basic was $0.27. FactSet's GAAP estimate was $0.20, so the real print beat by 30%. The $0.34 carried in the data feeds (vs $0.3222 est) is an ADJUSTED figure - Toast published no non-GAAP EPS at all. Both bases beat. They are not the same number, and several outlets labelled the $0.34 as GAAP.
    - THE 26% MARGIN IS A DIFFERENT DENOMINATOR. Management's quote says GAAP operating margins 'expanded to 26%'. Operating income was $152M: on $1,908M of revenue that is 8.0%; on $595M of recurring gross profit it is 25.5%. Both disclosed, both consistent - but the headline margin excludes ~80% of Toast's revenue. Tax was $8M on $162M pre-tax = 4.9%, shielded by a $982M accumulated deficit that shrank $280M in six months. At 24% the quarter earns ~$0.21.
    - ALL THE GROWTH IS NEW DOORS. GPV $60.7B across ~180,000 locations = $337k per location per quarter, vs $338k a year ago ($49.9B / ~147,500). Flat, fractionally down. ARR per location $13,383 vs $13,068, +2.4% - so 22 of the 25 points of ARR growth is location count. Subscription per location +4.4%, payments +0.5%. Toast now needs ~38,000 new doors a year to hold this rate. The good news: payments gross profit take rate ROSE to 49.8 bps from 48.9.
    - WORST CASH QUARTER, BUT REAL QUALITY. Net income +93% to $154M; free cash flow -37% to $130M. Two lines: inventory took $81M in the quarter and $103M over six months ($114M to $217M, on hardware revenue up 2%), and deferred commissions took $93M - the cost of a record quarter of net adds. On quality Toast passes: stock comp plus payroll tax FELL to $58M from $64M (3.0% of revenue vs 4.1%), diluted shares fell to 590M from 605M after $486M of buybacks at ~$25.58, ROIC is 20.9% vs 10.4% at Shopify and 7.2% at Block, subscription ARR ($1,210M) just passed payments ARR ($1,199M) for the first time, and subscription gross margin hit 77.9%.
    What to watch: Changes our mind UP: ARR per location growing above 6% for two straight quarters, or free cash flow recovering as the $103M inventory build unwinds. Confirms the bear: net location adds under 8,000 a quarter, or the take rate breaking below 48 bps. We'd buy at $25-$27, where Toast retired 19M shares at $25.58.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    14 min
  • Gilead (GILD): Revenue Beat, $10.5B Loss - And A Bar That Fell $9.50
    Gilead Sciences, Inc. (GILD) Q2 2026 — Q2 2026, quarter ended June 30, 2026. Revenue $7,803M, +10%, vs ~$7.37-7.40B consensus - a ~$400M beat. GAAP diluted EPS -$8.45 (net loss $10,496M); non-GAAP -$6.75 vs ~-$7.26 expected. Both driven by $11,183M of acquired IPR&D worth -$9.08/share. Add it back and the quarter earned $2.33 vs $2.01. HIV $5,693M +12%; Yeztugo $232M vs $15M. GILD closed $135.25 on Aug 4.
    Gilead beat on revenue by about $400 million, raised guidance, and reported a $10.5 billion net loss. All three are true because of one line: $11,183M of acquired in-process R&D expensed the day the Arcellx, Tubulis and Ouro deals closed, worth $9.08 a share. Add it back and the quarter earned $2.33 against $2.01. The catch is the bar it beat: full-year non-GAAP guidance went from +$8.65 in February to -$0.85 in May to -$0.48 on Tuesday.
    THE CALL: SELL (3/5, A VALUATION CALL, NOT A BUSINESS CALL) — base-case value ~$105.0 vs ~$135.25 today.
    KEY METRICS:
    - CALL: SELL 3/5, fair value ~$114 vs the $135.25 close (-16%). A 12-year DCF that crosses April 1 2036, when Gilead's settlements with Lupin, Cipla and Laurus let US generic Biktarvy in. We start from REPORTED free cash flow ($10,305M 2024, $9,456M 2025, $5,859M H1-26; we model $12.0B for 2026) then charge $1.5B/yr for buying the pipeline. At 7/8/9%: bear $71/$61/$53, base $124/$105/$90, bull $201/$165/$139; weighted 30/50/20 = ~$114. Six of the nine cells sit below the close. The Street: Buy, $158.67.
    - THE PRINT. Revenue $7,803M, +10%, vs ~$7.37-7.40B expected - a ~$400M beat. Product sales $7,627M (+8%), ex-Veklury $7,604M (+10%). GAAP operating loss $10,394M, net loss $10,496M, EPS -$8.45 vs +$1.56. Non-GAAP EPS -$6.75 vs +$2.01. Acquired IPR&D $11,183M (Arcellx $7.0B, Tubulis $3.1B, Ouro $1.0B net of Lakefront), plus a separate $1,750M impairment on Immunomedics assets. Check it: $9.08 x 1,243M shares = $11,286M. Add it back and the quarter earned $2.33 vs $2.01, +16%.
    - THE BAR FELL $9.50. Full-year non-GAAP EPS guidance, from the reconciliation table: Feb 10, $8.45 to $8.85. May 7, -$1.05 to -$0.65. Aug 4, -$0.65 to -$0.30. The midpoint dropped $9.50 in three months on deal charges alone, then rose $0.37 on Tuesday. Two published consensus figures sat $0.19 apart (-$7.26 and -$7.07) because every analyst had to guess the same charge - so the beat is $0.51 or $0.32 depending on whose arithmetic. The ~$400M revenue beat is the unarguable part.
    - THE RAISE, MEASURED. Ex-Veklury guidance went from $29,400-29,800M to $29,800-30,100M (+$400M), but Veklury was cut from ~$600M to ~$300M, so TOTAL product sales guidance moved only from $30.0-30.4B to $30.1-30.4B - the top end did not move. H1 ex-Veklury was $14,406M, so the guide implies $15,394-15,694M in H2 vs $14,759M last year: 4-6% growth against the 9% just delivered. Underlying H2 operating profit implies ~$7.16B vs $7.72B, -7%. Underlying FY EPS $8.43-$8.78 vs $8.97 in 2025.
    - WHAT THE DEALS COST, AND APRIL 2036. Cash fell from $10,605M to $3,179M in six months; equity from $22,618M to $11,744M. Uses: $11.3B acquisitions, $2.8B debt repaid, $2.1B dividends, $774M buybacks, funded by $4.1B of new debt and $6.1B of operating cash flow. Q2 free cash flow was $3,432M vs $720M - the operating business is fine. But Biktarvy did $14,334M in 2025, half of $28,915M of product sales, and Yeztugo is at $232M a quarter. HIV grew on 'higher average realized price and demand' - in that order, into an MFN pricing agreement.
    What to watch: Changes our mind UP: two years of acquired IPR&D under $1.5B while ex-Veklury sales compound above 6%, or Yeztugo clearing a $2B annual run-rate. Confirms the bear: another multi-billion deal expensed inside twelve months, or a concession on US HIV pricing under the most-favoured-nation agreement. We would buy at $105-$122.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    15 min
  • Pinterest (PINS): Beat On Every Line - And Stock Comp Bigger Than All The Profit
    Pinterest, Inc. (PINS) Q2 2026 — Q2 2026, quarter ended June 30, 2026. Revenue $1,179.7M, +18.2%, vs ~$1,148M consensus (+17% constant currency). Non-GAAP EPS $0.43 vs $0.36 expected. Adjusted EBITDA $311.3M vs $269.6M expected. GAAP net LOSS $46.7M; GAAP EPS -$0.08. Share-based comp $319.7M = 27.1% of revenue - larger than adjusted EBITDA. MAUs 640M, +11%. Q3 guide $1,190-1,210M (13-15%). PINS closed $25.58 on Aug 4, then fell ~9% after hours to ~$23.28.
    Pinterest beat on revenue, on adjusted EPS and on adjusted EBITDA - and the stock fell about 9% after hours. The reason is one line in the footnotes: Pinterest expensed $319.7M of stock compensation in the quarter, which is MORE than the $311.3M of adjusted EBITDA that add-back creates. That is 27.1% of revenue, versus 22.8% a year ago. Meta runs about 11%.
    THE CALL: HOLD (3/5, A REAL ACCELERATION THAT SHAREHOLDERS DO NOT OWN YET) — base-case value ~$24.0 vs ~$25.58 today.
    KEY METRICS:
    - CALL: HOLD 3/5, fair value ~$24 vs the $25.58 close (-6%) and ~$23.28 after hours (+3%). DCF on free cash flow AFTER charging every dollar of stock compensation, share count held flat. Base: revenue +13% fading to +9%, adjusted EBITDA margin 28% to 35%, SBC falling from 27% of revenue to 14% by 2031; economic FCF $275M in 2027 rising to $1,265M in 2031. At 10/11/12%: bear $8/$7/$6, base $27/$24/$21, bull $45/$39/$33. Reverse-DCF: $25.58 needs ~$1.4B of post-SBC free cash flow in 2031, a 17% margin, against approximately ZERO this year. Hold SBC at today's 27.1% of revenue and the whole equity is worth about $7.
    - THE BEAT IS REAL. Revenue $1,179.7M, +18.2%, vs ~$1,148M expected - the fastest growth in three years. Non-GAAP EPS $0.43 vs $0.36 (a 19% beat) and $0.33 a year ago. Adjusted EBITDA $311.3M vs $269.6M expected, a 26.4% margin. Free cash flow $269.9M. MAUs a record 640M, +11%, an 11th straight double-digit quarter. Q3 adjusted EBITDA guided $335-355M, above the Street. But on GAAP: a net LOSS of $46.7M against a $38.8M profit last year, EPS -$0.08 vs +$0.06, and a $55.2M operating loss. The gap between the GAAP loss and the $249.5M non-GAAP profit is $296M - 25% of revenue in add-backs.
    - STOCK COMP IS LARGER THAN THE PROFIT IT CREATES. Share-based compensation was $319.7M vs $227.2M, up 40.7% against 18% revenue growth - 27.1% of revenue vs 22.8%. Adjusted EBITDA was $311.3M. Revenue grew $181.4M; SBC grew $92.5M, so 51% of every incremental dollar went out as stock. R&D stock comp alone was $212.5M, +45.6%. The 10-Q discloses a further $1,443.8M granted and not yet expensed over 2.1 years - roughly $240,000 per employee per year across 5,265 staff, in stock alone.
    - SEVEN OF THE TEN CENTS CAME FROM THE BUYBACK. Adjusted net income grew 9.3% ($249.5M vs $228.3M). Adjusted EPS grew 30% ($0.43 vs $0.33). The entire difference is the diluted share count: 689.8M to 577.6M, -16.3%. Hold shares flat and that same profit is $0.36, not $0.43. Funding: on March 5 Pinterest sold $1.0B of 1.75% convertible notes due 2031 to Elliott Associates and Elliott International - disclosed as a RELATED PARTY - converting at $22.72, with $99.2M of capped calls pushing dilution to $30.59. H1 uses: $2,024.9M of buybacks, $180.5M of RSU tax withholding, $447.0M for tvScientific. Cash and securities fell $2,467M to $1,275M; equity fell $4,745M to $2,894M.
    - HOW MUCH OF THE 18% WAS REAL, AND THE GEOGRAPHY. Constant currency growth was 17%, not 18 - FX added $10.4M. Management flagged the Prime Day shift (~0.5pt) and World Cup spend (~1pt), both reversing in Q3. Underlying is nearer 15.5%, and Q3 is guided to 13-15%. By region: U.S. and Canada revenue $880M (+18%) at $8.30 ARPU on 106M users; Europe $213M (+12%) at $1.35; Rest of World $87M (+38%) at $0.23 on 377M users. So 59% of the audience produces 7% of the revenue and 17% produces 75%. Market cap computed ourselves: 492,198,008 Class A + 74,115,019 Class B = 566,313,027 shares (10-Q cover, Jul 29) x $25.58 = $14.5B - screens still print ~$17B off December's count.
    What to watch: Changes our mind UP: stock comp falling as a share of revenue two quarters running while growth holds in the low teens, or Rest-of-World ARPU lifting off $0.23. Confirms the bear: SBC above 26% while growth slips under 13%. We would buy at $17-$19 - where Pinterest itself bought $2.0B of stock at $18.17.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    14 min
  • DigitalOcean (DOCN): A 73% Earnings Beat — And Earnings Still Fell 24%
    DigitalOcean Holdings (DOCN) Q2 2026 — Q2 2026, quarter ended June 30, 2026. Revenue $281.2M, +28.6%, vs ~$279M consensus. Non-GAAP EPS $0.45 vs $0.26 expected - a 73% beat - but vs $0.59 a year ago. GAAP EPS $0.29. Pre-tax income $27.1M, -36%. Gross margin 55.0% from 59.9%. FY26 revenue guide RAISED to $1.170-1.180B (+30-31%); non-GAAP EPS guided $1.35-$1.40 vs $1.92 in 2025. DOCN opened $119.80 (-5.8%), closed $128.89, +1.35%.
    DigitalOcean beat adjusted EPS by 73% - 45 cents against 26 expected - and the stock still opened down 5.8%. That same 45 cents compares with 59 cents a year ago, so adjusted EPS FELL 24% while revenue grew 29%. And in the first half the company added $447M of lease-financed equipment against just $93M of cash capex.
    THE CALL: AVOID (4/5, A GENUINELY ACCELERATING BUSINESS AT A PRICE THAT REQUIRES A MIRACLE) — base-case value ~$55.0 vs ~$128.89 today.
    KEY METRICS:
    - CALL: AVOID 4/5, fair value ~$55 vs the $128.89 close - about 57% BELOW the price. Enterprise DCF on free cash flow after ALL capital spending, including lease-financed equipment, because a finance lease is a purchase. Base: 2027 revenue +40% to $1,645M, 38% EBITDA margin, all-in capex 35% of revenue falling to 18% by 2031; true FCF -$46M in 2027 rising to $578M in 2031. At 10/11/12%: bear $28/$24/$21, base $54/$45/$38, bull $104/$87/$74 - ALL NINE cells BELOW the price. Reverse-DCF: $128.89 needs ~$1.6B of true FCF in 2031, a 31% FCF margin on even our bull revenue - better than any hyperscaler earns.
    - THE BEAT IS REAL, AND SO IS THE DECLINE. Revenue $281.2M, +28.6%, vs ~$279M expected. Non-GAAP EPS $0.45 vs $0.26 consensus - a 73% beat, adjusted against adjusted. But the year-ago figure was $0.59, so adjusted EPS FELL 24% on +29% revenue. GAAP EPS $0.29 vs $0.39. Pre-tax income $27.1M vs $42.4M, -36%. GAAP net income fell only 4% because of an $8.3M tax BENEFIT against a $5.4M expense last year - a $13.7M swing unrelated to operations.
    - THE BAR WAS ON THE FLOOR, AND IT GOES LOWER. Consensus modelled $0.26 against $0.59 a year earlier - a 56% expected collapse. Now the guidance arithmetic: FY26 non-GAAP EPS guided $1.35-$1.40; H1 actual $0.89; Q3 guided $0.28-$0.30. Subtract and implied Q4 is ~$0.195 vs $0.44 in Q4 2025, down ~56% - in the very quarter revenue growth is guided past 35%. Full year vs $1.92 in 2025 is -27% to -30%.
    - $447M OF EQUIPMENT THAT NEVER TOUCHED CAPEX. Reported H1 'adjusted free cash flow' was +$62.8M (operating cash $156.9M less $81.6M property capex and $11.8M software). But finance lease and equipment financing obligations went from $130.5M at Dec 31 to $577.7M at Jun 30 - $447M in six months - while net PP&E grew $460M. A finance lease is a purchase financed with debt. Charge it honestly and H1 free cash flow is about -$384M, not +$63M.
    - $5.1B OF COMMITMENTS AGAINST $767M OF CASH, AND AN 11.2-YEAR DURATION MISMATCH. On balance sheet: debt $921M + finance leases $578M + operating leases $479M = $1.98B. Off balance sheet (10-Q Notes 7-9): $2,759M of data-centre leases NOT yet commenced, $282M servers, $128M software = $3.17B more. Those leases run a weighted-average 11.2 YEARS while management celebrates extending customer contract life from 1.6 to just over 3 years. Gross margin 55.0% vs 59.9%, -488bps, as D&A rose 56% to $51.2M. Shares: 91.9M (Dec 31) to 105.0M (Jun 30) to 117,579,550 (Jul 30 cover).
    What to watch: Changes our mind UP: finance-lease growth decelerating two straight quarters while revenue compounds, and gross margin stabilising. Confirms the bear: the implied ~$0.195 Q4 actually printing. We'd get interested at $60-$70.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    14 min
  • TransDigm (TDG): Beat, Raised Guidance, Closed Red — Is TDG Stock a Buy?
    TransDigm Group (TDG) Q3 FY2026 — Fiscal Q3 2026, the 13 weeks ended June 27, 2026. Net sales $2,741M, +22.5% (organic +13%), vs ~$2.68B consensus. Adjusted EPS $10.87 vs $10.30 expected and $9.60 LY. GAAP EPS $9.39. EBITDA As Defined $1,447M, +18.9%, margin 52.8% from 54.4%. Interest expense $514M, +29.5%. FY26 guidance RAISED: sales $10,470-10,550M, adj EPS $40.62-41.46. TDG opened $1,355.60 (+5.5%), hit $1,359.27, closed $1,275.05 — red on the day.
    TransDigm beat on both lines and raised full-year guidance, and the stock still finished the session red — 6.2% below its own opening high, on nearly double normal volume. The reason is one line. Interest expense rose $117M year over year, which is $1.54 a share after tax. Adjusted EPS rose $1.27. The increase in the interest bill was larger than the entire increase in earnings. EBITDA As Defined is guided up 16% this year; free cash flow is up about 8%.
    THE CALL: HOLD (3/5, A GREAT BUSINESS AT A FAIR PRICE — THE INTEREST BILL IS NOW THE STORY) — base-case value ~$1355.0 vs ~$1275.05 today.
    KEY METRICS:
    - CALL: HOLD 3/5, fair value ~$1,355 vs the $1,275.05 close - about 6% ABOVE the price, less than one year's cost of capital. Cash-to-EQUITY DCF: free cash flow after interest, cash tax and the full capital budget, PLUS the borrowing capacity a constant 5.8x leverage creates, because that capacity funds the buybacks. FY2027 owner cash $2.90B growing 11% fading to 4%. At 9%: bear $889, base $1,357, bull $1,819. At 8% base is $1,708; at 10%, $1,123. 5 of 9 grid cells sit ABOVE the price and 4 below - a fair price, not a mispricing. Reverse-DCF: today's price is our base case at a 9.35% cost of equity.
    - THE BEAT AND THE RAISE ARE BOTH REAL. Net sales $2,741M, +22.5% ($504M), vs ~$2.68B expected. Adjusted EPS $10.87 vs $10.30 consensus and $9.60 LY - like-for-like, both adjusted and diluted. GAAP EPS $9.39 vs $8.47. FY26 adjusted EPS guidance went from a $39.52 midpoint (May 5) to $41.04, up $1.52 against only a 57c quarterly beat - so ~95c is genuine FORWARD raise.
    - HOW MUCH OF THE 23% DID THEY BUY? The release says organic growth was 13%: ~$291M of the $504M increase, so ~$213M (42%) was acquired. Reported aftermarket went $698M to $908M (+30.1%) but the CEO said 17% - the gap is Jet Parts Engineering / Victor Sierra, the $2.2B deal closed April 7. Commercial OEM +19.2%; Defense +19.2% with backlog building.
    - WHERE THE 160 BASIS POINTS WENT - management's explanation CHECKS OUT. EBITDA As Defined margin 52.8% vs 54.4%. Power & Control (where the deals landed) earned $808M on $1,509M = 53.5%, down from 56.7%, -316 bps. Airframe, which bought nothing, earned $645M on $1,186M = 54.4%, UP from 53.8%. The base business expanded; the acquired book dilutes the average.
    - EBITDA UP 16%, FREE CASH FLOW UP 8% - one line explains it. 39-week operating cash flow $1,691M less $205M capex = $1,486M FCF vs $1,375M (+8.1%), while revenue was +18.4%. Cash interest paid $1,210M vs $908M, +33%. Gross debt $33.5B vs $2,773M cash = $30.7B net, 5.8x. Guided FY26 interest of $2,020M is 36.6% of the $5,520M EBITDA As Defined guide. The raised guide implies a Q4 margin of 52.3% vs 54.1% LY - MORE compression. Shares out 55,276,525 (10-Q cover) x $1,275.05 = $70.5B; EV $101.2B.
    What to watch: Changes our mind UP: EBITDA As Defined margin stabilising for two quarters, and free cash flow growing in line with EBITDA again. Confirms the bear: another debt-funded acquisition while margins keep sliding and Q4 lands at the implied 52.3%. We would get interested near $1,100.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    16 min
  • Tower Semiconductor (TSEM): Record Quarter, Negative Free Cash Flow — Is TSEM Stock a Buy?
    Tower Semiconductor (TSEM) Q2 2026 — Q2 2026, quarter ended June 30. Revenue $460.1M, +23.7% YoY, vs ~$463.8M consensus (a MISS). GAAP EPS $0.80 basic / $0.79 diluted; adjusted diluted $0.88 vs $0.77. Gross margin 29.9% from 21.5%. Operating profit $90.3M, 2.26x. Q3 guide $520M, a record. TSEM closed $239.53, +2.2%.
    Tower posted its best quarter ever and guided to a record. Then we split the revenue line in two. Silicon photonics went from a $180M annual run rate to $680M - about +$125M in the quarter. Total revenue grew $88.0M. So everything else Tower makes shrank ~$37M, roughly 11% YoY. Record profit also came with NEGATIVE free cash flow (-$9.6M), and 84% of this year's net-cash build is customer prepayments, not earnings.
    THE CALL: AVOID (4/5, A REAL INFLECTION, AT A PRICE THAT ALREADY ASSUMES IT WORKED) — base-case value ~$160.0 vs ~$239.53 today.
    KEY METRICS:
    - CALL: AVOID 4/5, fair value ~$160 vs $239.53 - about 33% BELOW the price. Owner-earnings DCF charging the FULL capital budget, expensing stock comp, 15% cash tax (Pillar Two ends Israel's 7.5% preferred rate), net cash added back at $1.018B after removing $321M of customers' advances, over 114.4M diluted ORDINARY shares. At 10%: bear $80, base $144, bull $200. NONE of the nine grid cells reaches $239.53. Reverse-DCF: today's price requires a SUSTAINED ~63% gross margin. Tower earned 29.9%; TSMC ~59%; UMC ~30%.
    - THE RECORD IS ONE PRODUCT LINE. SiPho ran at a $680M annual rate in Q2-26 (~$170M in the quarter) vs $180M a year ago (~$45M) - up ~$125M. TOTAL revenue rose $88.0M, $372.1M to $460.1M. So everything else - RF/SiGe, power BCD, image sensors, MEMS, displays - went from ~$327M to ~$290M, DOWN ~11% YoY. SiPho is now ~37% of revenue, from ~12%. Management targets a $1B SiPho run rate in Q4-26 and raised the 2028 model to $3.6B revenue / $1.2B net profit.
    - THE MARGIN GAIN IS MIX, NOT LOADING - the best fact in the bull case. Gross profit rose $57.7M ($80.0M to $137.8M, +72%) on $88.0M more revenue = a 65.6% incremental gross margin. Charge the legacy book's -$37M at a 20% contribution margin and SiPho added ~$65M of gross profit on ~$125M of revenue - a ~52% incremental gross margin. Absorption reverses; mix sticks. P&L: COGS $322.3M, R&D $23.6M, MG&A $23.9M, operating profit $90.3M (19.6%), tax 14.7%, net attributable $90.8M.
    - RECORD PROFIT, NEGATIVE FREE CASH FLOW. Q2 operating cash flow $177.0M less $186.6M capex = -$9.6M. Capex ran 2.23x the $83.6M of D&A. The half-year looks better ($686.9M vs $343.0M) but $282.6M of it is CUSTOMERS' ADVANCES; strip them and H1 FCF is $61M against $155.8M of net profit. Net cash $1.340B rose $349M this year while customer advances rose $294M - 84% of the build is prepayments.
    - WHAT THE FILING SAYS QUIETLY. 'Record operating profit (excluding non-recurring items)' excludes Intel's $353M break fee from the collapsed $5.4B takeover. Risk factor (xxxvii) discloses Intel's determination NOT to perform the capacity-corridor deal - the $300M New Mexico 300mm arrangement is in mediation; Tower's US path is replaced by Japan (new fab beside Fab 7, Arai, METI grants) and shared Agrate with STMicro. Cross-check needing no forecast: 8.81x book ($3.071B equity) on a trailing ROE of 11.8% implies a sustainable ROE near 65%; TSMC earns ~35%. FOREIGN ISSUER: reports in USD (no FX) and lists ORDINARY SHARES, not ADSs.
    What to watch: Changes our mind UP: the non-photonics book growing again for two straight quarters, FCF positive after capex with advances stripped out, or gross margin through 35%. Confirms the bear: legacy still shrinking at year-end, or advances falling while growth slows. We would start looking near $160.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    15 min
  • Kratos (KTOS): Revenue +30.5%, A Double Beat — And An Operating LOSS. Is KTOS Stock a Buy?
    Kratos Defense (KTOS) Q2 2026 — Reported Aug 4, 2026 for Q2 2026, the quarter ended June 28. Revenue $458.8M, +30.5% YoY (+19.1% organic), vs ~$410.4M consensus. Adjusted EPS $0.21 vs $0.14 expected. GAAP EPS $0.02. Adjusted EBITDA $38.2M. FY26 revenue guide raised to $1.75-1.81B. KTOS closed $51.87, +5.4%.
    Kratos posted a double beat and raised guidance. Then we read the operating line: GAAP operating income was MINUS $1.6M, against PLUS $3.7M a year earlier. All $4.4M of net income traces to $10.2M of interest income on the $1.44B shareholders handed over in two equity offerings. Diluted shares rose 20.8%, so revenue per share grew 8.1%, not 30.5% - and the company guides FY26 free cash flow to a USE of $85-105M.
    THE CALL: AVOID (4/5, A REAL BUSINESS AT A PRICE ITS OWN CASH GUIDE CANNOT SUPPORT) — base-case value ~$26.0 vs ~$51.87 today.
    KEY METRICS:
    - CALL: AVOID 4/5, fair value ~$26 vs $51.87 - about 50% BELOW the price. Ten-year owner-earnings DCF (adjusted EBITDA less stock comp, less cash tax, less capex, less the working capital growth eats): revenue compounding 20% next year fading to 4%, EBITDA margin 10.8% to 14.4%, capex 7.0% to 3.5% of sales, 10% discount, 3.5% terminal = $2.60B enterprise, plus $1.30B net cash, over 187.7M shares = $20.74. Bear $10, bull $33. A 20x multiple on 2028E EBITDA cross-checks to ~$30. NONE of the nine grid cells reaches $51.87.
    - A DOUBLE BEAT WITH A GAAP OPERATING LOSS. Revenue $458.8M, total costs $358.7M, gross profit $100.1M; then SG&A $73.3M, R&D $13.6M, M&A $0.8M, depreciation $3.9M, amortisation $10.1M - operating income MINUS $1.6M, against PLUS $3.7M on $351.5M of revenue a year ago. Pre-tax income of $7.0M contains $10.2M of interest income (vs a $1.2M expense last year). Strip the interest and Kratos was pre-tax negative. GAAP EPS $0.02, unchanged YoY.
    - REVENUE +30.5%. REVENUE PER SHARE +8.1%. Diluted shares 190.1M vs 157.4M, up 20.8%. Revenue per diluted share $2.41 vs $2.23. Kratos sold 14.9M shares at $38.50 in Jun 2025 ($555.9M net) and 16.4M at $84.00 on Feb 26 2026 ($1,348.4M net); paid-in capital $2.64B to $4.05B in six months; $346.8M of that cash bought Nomad and Orbit, which is the gap between 30.5% reported and 19.1% organic. On May 20 the charter raised authorised shares from 195M to 245M.
    - THE COMPANY GUIDES NEGATIVE FREE CASH FLOW. FY26 adjusted EBITDA $173-176M, stock comp $60-64M, so cash EBITDA is ~$112M - LESS than the guided $125-135M of capex. Guided operating cash flow $30-50M and guided FY26 free cash flow USE of $85-105M. Q2 operating cash flow was -$11.0M; capex $17.2M; true FCF -$28.2M (Kratos reports -$18.9M by netting $9.3M of Valkyrie asset sales). H1 true FCF -$75.5M. Backlog $2.084B is 1.17x one year of revenue; funded backlog $1.572B.
    - MARGIN IS NOT SCALING. Adjusted EBITDA margin 8.05% to 8.33% - 28bp - on 30.5% more revenue, while SG&A grew 35.5%. Government Solutions (+36.4%, +22.0% organic, $379.7M) saw its adjusted EBITDA margin FALL, 8.88% to 8.72%; Unmanned Systems ($79.1M, +8.1% organic) rose 4.92% to 6.45%. EV $8.43B = 48x FY26 guided adjusted EBITDA, 75x cash EBITDA and 4.7x sales; Leidos trades at 0.9x sales, L3Harris 2.3x. Balance sheet is genuinely strong: $1.4376B cash, no term debt, $1.30B net cash.
    What to watch: Changes our mind UP: two straight quarters of positive free cash flow after capex, adjusted EBITDA margin above 11%, or a 2027 guide with capex falling in dollars. Confirms the bear: another equity raise below $60, FY26 FCF use worse than $105M, or KGS margin falling again. We would start looking under $30. We are NOT recommending shorting it.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    15 min
  • Astera Labs (ALAB): Revenue +104%, A Clean Beat — And Our Call Is SELL. Is ALAB Stock a Buy?
    Astera Labs, Inc. (ALAB) Q2 2026 — Reported Aug 4, 2026 AFTER the close (release 4:05pm ET) for Q2 2026, the quarter ended June 30. Revenue $392.4M, +104.5% YoY and +27.3% QoQ, vs ~$360M consensus. Non-GAAP EPS $0.80 vs $0.64 expected. GAAP EPS $0.83. Q3 guide $540-560M. ALAB closed $361.67, +12.65% - but that move is PRE-print.
    Astera Labs printed a record quarter and the operating beat is real: revenue +104%, non-GAAP operating margin 39.1%, Scorpio X in volume a quarter early. Then we read the cash-flow statement: first-half revenue doubled to $700.8M and free cash flow FELL, $139.3M to $134.2M. After $112.9M of stock comp, owner earnings for the half were $21.3M - against a $62B market cap.
    THE CALL: SELL (3/5, AN OUTSTANDING QUARTER AT A PRICE THAT NEEDS NINE MORE) — base-case value ~$186.0 vs ~$361.67 today.
    KEY METRICS:
    - CALL: SELL 3/5, fair value ~$185 vs $361.67 - about 49% BELOW the price. Nine-year owner-earnings DCF: 2027E revenue $3,150M at 71.5% gross margin less 41.5 pts of opex = $945M GAAP operating income (stock comp inside), less 14% cash tax, less capex and $156M of working capital = $625M owner FCF; revenue compounding 23%/yr to $12.5B by 2035 at a 39% terminal margin, 10.5% discount = $35.0B enterprise, plus $1.25B net cash, over ~195M shares = $186. Bear $87, bull $320.
    - GAAP EPS $0.83 BEAT NON-GAAP EPS $0.80 - a warning, not a win. Pre-tax income $102.8M, then an income tax BENEFIT of $50.3M: a MINUS 48.9% rate. Tax that at the 12% the company uses on its own non-GAAP line and net income is ~$90.5M, or ~$0.49 a share - so ~$0.34 of the GAAP headline is tax, not operations. The $0.80 non-GAAP beat IS real ($153.5M operating income, 39.1% margin). Q3 guides GAAP EPS $0.87-0.92 BELOW non-GAAP $1.16-1.21 - the benefit is not expected to repeat.
    - REVENUE DOUBLED AND FREE CASH FLOW WENT DOWN. H1 2026: revenue $700.8M (+99%), OCF $162.3M, capex $28.1M, FCF $134.2M. H1 2025 on half the revenue: FCF $139.3M. That is -3.7%. Cause is a ramp, not a fraud: receivables $83.2M to $192.5M (~45 days), inventory $59.0M to $113.8M (~99 days of COGS), prepaids tripled - $204M of working capital consumed in six months. Subtract H1 stock comp of $112.9M and owner earnings were $21.3M against a $61.99B market cap.
    - THE INFLECTION IS MARGIN-DILUTIVE. Non-GAAP gross margin 76.4% (Mar) to 73.7% (Jun) to a guided 72.0% (Sep) - 440bp in two quarters, as Scorpio X switches (more silicon than retimers) become the largest line. The bull case survives: 72% of a $550M midpoint = $396M gross profit, less $156-160M non-GAAP opex = ~$238M operating profit, a 43.3% margin UP from 39.1%. Revenue +40%, gross profit +37%, operating profit +55%, opex only +16%.
    - CONCENTRATION: the Q1 2026 10-Q shows five direct customers at 29/21/16/12/12% of revenue - 90% in five names, the largest up from 12% a year earlier. 'Warrants contra revenue' was $12.3M in H1 vs $2.1M - the Amazon warrant, netted off reported revenue. Cash + securities $1.25B, ZERO debt. STREET: consensus Buy (13/5/0) but the $301.82 average target and $275 median sit BELOW the $361.67 close, the average by 16.5%. We DIFFER.
    What to watch: Changes our mind UP: FCF above 20% of revenue for two straight quarters, or the largest customer back under 20%. Confirms the bear: gross margin guided below 70%, or receivable days past 60. We would start buying under $200. We are NOT recommending shorting it.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    15 min
  • Lattice (LSCC): Revenue +62%, A Clean Beat — And Our Call Is SELL. Is LSCC Stock a Buy?
    Lattice Semiconductor Corporation (LSCC) Q2 2026 — Reported Aug 4, 2026 AFTER the close (call 5:00pm ET) for fiscal Q2 2026, the quarter ENDED JULY 4. Revenue $201.1M, +62.2% YoY, vs ~$185.5M consensus and a $175-195M guide - above its own HIGH end. Non-GAAP EPS $0.53 vs $0.44 expected, guide $0.42-$0.46. GAAP EPS $0.14. LSCC closed $138.00, +8.5% - but that move is PRE-print.
    Lattice printed a record quarter and we could not break it: revenue +62%, a 20% non-GAAP EPS beat, no AMI revenue in the period, share count UP not down, and the tax rate worth half a cent. It is an excellent print. Then we valued it. Expense the $50.3M of stock compensation - 25% of revenue - and owner free cash flow is $31M, not the $81.3M reported. At $138 the price needs owner earnings compounding 21.7% a year for TEN straight years. Our number is ~$70.
    THE CALL: SELL (3/5, A GREAT QUARTER AT A PRICE THAT NEEDS TEN MORE) — base-case value ~$69.0 vs ~$138.0 today.
    KEY METRICS:
    - CALL: SELL 3/5, fair value ~$70 vs $138.00 - about 49% BELOW the price. Ten-year owner-earnings DCF: FY2027E revenue $1,304M at a 71.5% gross margin less 28.5 pts of opex = $561M non-GAAP EBIT, less $176M of stock comp, less interest on the $925M term loan and a 15% tax = $271M owner FCF; grown 24/20/17/14/12% then 10/8/7/6/5%, 3% terminal at 9.5% = a $10.62B enterprise, less $0.78B pro-forma net debt, over 142.0M shares = $69. Bear $34, bull $114. Only ONE of nine grid cells reaches $138.
    - THE BEAT IS REAL - WE RAN THREE CHECKS. (1) No AMI: the $1.65B deal closed July 27, 23 days AFTER the quarter ended; goodwill is $315.4M, unchanged to the dollar from January, and there were NO borrowings at July 4. (2) No buyback: diluted shares rose 140.2M vs 137.6M, UP 1.9% - non-GAAP net income +128% vs EPS +121%, the gap IS dilution. (3) No tax trick: non-GAAP tax 4.3% vs 5.4% last year, worth half a cent. Non-GAAP opex $67.1M came in ABOVE their own $67M ceiling and they still beat by 20%.
    - THE COST NOBODY DEDUCTS: non-GAAP operating income $77.1M vs GAAP $22.4M. Of that $54.7M gap, $50.3M is stock comp ($44.9M) plus incentive pay settled in shares ($5.4M) - 25.0% of revenue. Reported FCF $81.3M (40.4% margin) less $50.3M = $31.0M, a 15% margin, ~$124M annualised against a $19.60B market cap. And it is not abstract: LSCC paid $29.7M CASH in H1 for RSU tax withholding, twice the $15.0M of buybacks, so the share count ROSE.
    - READ THE GUIDE SEQUENTIALLY, NOT YoY. Q3 midpoints, all non-GAAP: revenue $255M vs $201.1M = +26.8%. Gross margin 69.5% vs 71.7% = -220bp. Opex $86.5M vs $67.1M = +28.9%. That implies operating income $90.7M vs $77.1M = +17.6%, margin 35.6% vs 38.3%. And EPS $0.56 vs $0.53 = +5.7%. Revenue +27%, profit +18%, earnings +6%. The wedge is ~$9M of interest on the $925M term loan drawn July 27, about 6 cents a share. AMI buys revenue, not much first-quarter profit.
    - MIX, CONCENTRATION AND THE BALANCE SHEET: Compute & Communications $126.0M (+83%, now 63% of revenue vs 55%); Industrial & Embedded $75.1M (+36%). Asia +92% 'primarily due to hyperscaler demand' and now 79% of revenue; Americas -14%, down to 12% from 22%. Distribution is 95% of revenue vs 84%, and the two largest distributors are 49% and 39% of net receivables. Inventory days 153 (vs 218 a year ago but 151 last quarter). At July 4: $173.3M cash, ZERO debt. Three weeks later: $925M drawn. STREET: consensus Strong Buy, $121.12 average target - already 12% BELOW the $138 close. We DIFFER.
    What to watch: Changes our mind UP: stock compensation under 15% of revenue for two straight quarters, or AMI gross margin above 75% with combined non-GAAP operating margin holding 40%, or the Americas returning to growth. Confirms the bear: inventory days back above 180, a distributor cutting orders, or non-GAAP gross margin below 68%. Hard rule: if net leverage passes 2.5x EBITDA we cut to a stronger sell. We would buy under $75. We are NOT recommending shorting it.
    Also on YouTube: @ChargedAlpha
    DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.
    14 min

About Charged Alpha Stock Encyclopedia

From the publisher's feed

⚡ Charged Alpha — The S&P 500 Stock Encyclopedia Data-driven deep dives into every stock in the S&P 500 after every earnings report. Each episode breaks down one company from open to close:…